| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |